Meihua CEO Lee Leyi files initial Form 3

Meihua International Medical Technologies Co., Ltd. CEO Lee Leyi has filed an initial insider ownership report on Form 3.

Accepted by SEC EDGAR 03/30/2026 - 12:03 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

Meihua International Medical Technologies Co., Ltd. CEO Lee Leyi has filed an initial insider ownership report on Form 3. The data provided shows no reported transactions or derivative positions, and no current holding entries are listed for this reporting person.

Key Figures

Reported buy transactions: 0 Reported sell transactions: 0 Net buy/sell shares: 0

3 metrics

Reported buy transactions 0 Form 3 transactionSummary buyCount

Reported sell transactions 0 Form 3 transactionSummary sellCount

Net buy/sell shares 0 Form 3 transactionSummary netBuySellShares

Key Terms

reporting person, transaction summary, derivative summary

3 terms

reporting person regulatory

"reportingPersons list identifies CEO Lee Leyi as the reporting person"

transaction summary financial

"transactionSummary aggregates buy, sell, and other insider actions"

derivative summary financial

"derivativeSummary shows remaining derivative positions, which are none here"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does Meihua International (MHUA) CEO Lee Leyi’s Form 3 filing show?

The Form 3 for CEO Lee Leyi shows an initial insider ownership report for Meihua International Medical Technologies. In the provided data, there are no reported transactions, derivative positions, or holding entries associated with the reporting person.

Are there any buy or sell transactions in MHUA CEO Lee Leyi’s Form 3?

No. The transaction summary for CEO Lee Leyi’s Form 3 shows zero buys, zero sells, and zero derivative transactions. It is purely an initial statement with no reported trading activity in the provided information.

Does Meihua International CEO Lee Leyi report any derivatives on this Form 3?

No derivative positions are reported for CEO Lee Leyi. The derivative summary is empty and the transaction summary shows no exercises or derivative transactions, indicating no listed options, warrants, or similar instruments in this dataset.

What does a netBuySellDirection of neutral mean in this MHUA Form 3?

A neutral netBuySellDirection reflects that there are no net purchases or sales reported. For CEO Lee Leyi’s Form 3, all buy and sell counts and share totals are zero, resulting in a neutral transaction direction overall.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Lee Leyi

(Last) (First) (Middle)

RM 2618 POK MAN HSEPOK HONG ESTSHATIN NT

(Street)

HONG KONG SAR 00000

(City) (State) (Zip)

CHINA

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
Meihua International Medical Technologies Co., Ltd. [ MHUAF ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CEO

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

No securities are beneficially owned.

	Leyi Lee	03/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)